Cipla’s generic Covid-19 drug lands in SA but the state isn’t buying it
Remdesivir would sell for almost R6,000 for a five-day course, markedly less than overseas
03 August 2020 - 18:19
UPDATED 03 August 2020 - 19:44
SA’s biggest private hospital groups have obtained supplies of Indian drug manufacturer Cipla’s cut-price generic version of the coronavirus drug remdesivir, which speeds up recovery in severely ill patients.
However, a question mark hangs over whether state patients will benefit as the company is yet to receive orders from provincial health departments...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.